ReLab

What ReLab does

ReLab is a French medtech company that was founded in 2020 and operates a B2B digital marketplace (labmedical.shop) for medical devices, in-vitro diagnostic (IVD) reagents, consumables, and laboratory equipment. The platform serves healthcare professionals — including hospitals, medical analysis laboratories, blood banks, and clinics — by aggregating supply from multiple manufacturers and distributors into a single purchasing interface with harmonized, volume-optimized pricing. The company is incorporated as Relab SAS, headquartered at Parc Eurasanté in Loos (Lille metropolitan area), with a stated service footprint spanning Europe, Africa, and the Middle East.

The underlying technology is a dual-sided e-commerce marketplace with ERP connectors that synchronize customer procurement systems to the platform, plus a complementary 'ReLab On Demand' service that lets buyers request products not currently listed. ReLab also captures transaction and consumption data (categories, periodicity, volumes) to support both buyer-side monitoring and seller-side obligations under European MD and IVD market surveillance regulations. The product surface is organized into three categories — DM/DMDIV (rapid tests and molecular biology reagents), Consumables (lab, hospital, community, and home-care), and Laboratory Equipment (from glassware to automated analyzers) — combining third-party catalogs with ReLab's own product range.

ReLab generates revenue through two streams: direct product sales of its own medical device range via the marketplace, and transaction-based commissions on third-party manufacturer/distributor sales facilitated on the platform. Pricing is pay-as-you-go with volume-based optimization for buyers. The go-to-market relies on a bilingual (French/English) website, content marketing, regional trade show participation (e.g., EMEA Connect), and the On Demand request service for direct enterprise engagement. The company is privately held with three co-founders (Nicolas Viéville, Mickael Dupont, Alexis Delanoë) and supported by regional French backers including BPI France, Hauts-de-France Region, Métropole Européenne de Lille, Réseau Entreprendre, and the Eurasanté medtech cluster.

Name

ReLab

Legal name

Relab SAS

Website

https://relab-diagnostics.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

ReLab (Relab SAS) is a French medtech company that operates a B2B digital marketplace (labmedical.shop) connecting healthcare professionals — hospitals, labs, blood banks, and clinics — with manufacturers and distributors of medical devices, IVD reagents, consumables, and laboratory equipment across Europe, Africa, and the Middle East.

Ownership category

akta.pro rank

Product category

Medical Device Marketplace

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Laboratory Analytical Instruments (3826), Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH)

Keywords

• Medical device marketplace
• IVD reagents distribution
• Laboratory equipment supply
• B2B healthcare procurement
• Medical consumables trading

Headquarters

HQ city

Loos

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Marketplace Product Sales: ReLab commercializes its own range of medical devices (reagents, consumables, equipment) through its online marketplace platform, generating revenue from product sales to healthcare facilities.
2. Third-Party Marketplace Commission: Facilitates transactions between third-party manufacturers/distributors and healthcare buyers on the marketplace, earning commission on volume-based transactions with harmonized pricing.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

ReLab operates a B2B digital marketplace (labmedical.shop) connecting healthcare professionals — hospitals, medical analysis laboratories, blood banks, and clinics — with manufacturers and distributors of medical devices, IVD reagents, consumables, and laboratory equipment across Europe, Africa, and the Middle East. The platform also commercializes ReLab's own product range and offers a custom sourcing service (ReLab On Demand) for products not listed on the marketplace.

Product overview

ReLab is a medtech company operating a digital B2B marketplace (labmedical.shop) for medical devices and IVD products. The platform offers three main product categories: MD/IVDMD (medical devices including rapid tests and molecular biology reagents), Consumables (laboratory and healthcare consumables), and Laboratory Equipment (from basic glassware to automated analyzers). An additional service, ReLab On Demand, enables users to request products not currently listed on the platform. The marketplace serves healthcare professionals (hospitals, medical analysis labs, blood banks, clinics) and connects them with manufacturers and distributors, offering harmonized pricing, ERP connectors, and compliance with European MD and IVD regulations.

Differentiator

Problem solved

Functional benefit

Products and services

• ReLab Marketplace (labmedical.shop) Digital B2B marketplace where healthcare facilities order medical devices, IVD reagents, consumables, and laboratory equipment online with volume-based pricing, harmonized contracts, and ERP integration. The platform also commercializes ReLab's own product range and aggregates third-party manufacturers and distributors.
• ReLab On Demand Custom product sourcing service enabling healthcare buyers to submit requests for products not currently listed on the marketplace, with rapid response capability delivered through ReLab's integrator expertise.
• DM/DMDIV (Medical Devices and IVD) Range of medical devices and IVD products including rapid tests and molecular biology reagents, sourced from recognized manufacturers and ReLab's own product range, sold through the labmedical.shop marketplace.
• Consumables Wide range of consumables used in laboratories, hospitals, city medicine, and home care, available through the labmedical.shop marketplace.
• Laboratory Equipment Laboratory equipment ranging from basic glassware to complex automated analyzers, offered through the labmedical.shop marketplace.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor and core.

• CCI (Chambre de Commerce et d'Industrie)minorImplementation/ SI/ Consulting Partner · 1 January 2020Chamber of Commerce and Industry providing business support services. Logo displayed in supporters section.
• EurasantécoreStrategic or Co-development Partner · 1 January 2020Health innovation cluster in the Lille metropolitan area supporting medtech companies. Hosted at Parc Eurasanté business park where ReLab is headquartered. Provides networking, incubation, and partnership development services for healthcare companies.
• Init. Lille-Métropole SudminorStrategic or Co-development Partner · 1 January 2020Local entrepreneurship support initiative. Logo displayed in supporters section indicating startup support relationship.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cardinal Health: U.S.-based medical product distributor serving hospitals, laboratories, and clinics across a broad portfolio. Comparable to ReLab in serving healthcare procurement but with global logistics and incumbent advantage.
• Medline Industries: Privately held manufacturer and distributor of medical supplies and clinical solutions for hospitals and labs. Comparable in scale of medical-supply distribution but with broader product portfolio.
• Henry Schein: Distributor of medical and dental supplies, including consumables, equipment, and IVD products, to office-based practitioners and labs. Overlaps with ReLab's medical-device/catalog focus but with much larger reach.
• Bio-Rad Laboratories: Manufactures and supplies life-science research and clinical diagnostic products including reagents and instruments. Overlaps with ReLab's IVD reagent and lab-equipment categories, though as a manufacturer rather than marketplace.
• McKesson Corporation: Global wholesale distributor of medical devices, IVD products, and pharmaceuticals to hospitals and laboratories. Overlaps with ReLab's buyer base but operates at vastly greater scale and breadth.
• Thermo Fisher Scientific (Fisher Scientific channel): Supplies laboratory equipment, analytical instruments, reagents, and consumables globally through its Fisher Scientific channel. Comparable in lab-supply product categories sold via ReLab's marketplace.
• Avantor (formerly VWR International): Global distributor of laboratory supplies, equipment, and consumables to research and clinical labs. Directly comparable to the lab-supply catalog portion of ReLab's marketplace.

Direct peers

• GHX (Global Healthcare Exchange): Operates a B2B healthcare supply-chain network/marketplace connecting providers with medical device manufacturers. Directly comparable to ReLab's buyer-seller aggregation model in medical devices and consumables.

Others

• Doctolib: Leading French digital health platform offering appointment booking and increasingly health-services commerce. Adjacent as a French healthtech peer with marketplace-style network dynamics, though operating in a different vertical.

Emerging players

• Alibaba Health: Operates digital health and pharmaceutical commerce platforms in Asia. Comparable as a health-vertical e-commerce/marketplace operator, though serving different geographies than ReLab's EMEA focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/relab-diag

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ReLab